Skip to main content
Clinical Trials/NCT00350909
NCT00350909
Completed
Phase 2

Brief Intervention for Drug Abusing Students

University of Minnesota1 site in 1 country160 target enrollmentSeptember 2005
ConditionsDrug Abuse

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Drug Abuse
Sponsor
University of Minnesota
Enrollment
160
Locations
1
Primary Endpoint
Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Detailed Description

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills. Specifically, we propose a randomized clinical trial to evaluate the efficacy of a cognitive-behavioral therapy on key process and outcome dimensions among school-based youth with mild-to-moderate drug abuse (MMDA). The experimental treatment is designated Brief Cognitive Behavioral Intervention (BCBI) given its theoretical foundation in stage of change theory used to coordinate modules on Rational-Emotive Therapy and Problem Solving Therapy. BCBI will be compared against a second experimental treatment that consists of BCBI and a single parent session (BCBI+P) and an assessment only condition (control). The importance of clarifying mechanisms in drug treatment research will be explored with respect to a limited number of treatment and individual factors that have emerged as promising mediating and moderating factors, such as cognitive and problem solving factors, parenting practices, and peer group influences.

Registry
clinicaltrials.gov
Start Date
September 2005
End Date
July 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • student at a local school
  • meets DSM-IV criteria for a substance abuse disorder for at least one drug
  • student and parent both agree to participate in the intervention study

Exclusion Criteria

  • meets criteria for at least one DSM-IV substance dependence disorder
  • meets criteria for a psychotic disorder or a learning disability

Outcomes

Primary Outcomes

Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.

Time Frame: 1 year post treatment

Secondary Outcomes

  • HIV and sexual risk behaviors at the same time period.(1 year post treatment)

Study Sites (1)

Loading locations...

Similar Trials